One explanation for this discrepancy may be that traditional immunocytochemistry methods only measure epithelial antigens such as cytokeratin and EpCAM, which can be frequently downregulated in metastatic tumor cells or cells that revert to a ‘stem cell-like’ phenotype [14, 15]. The gene discussed is EPCAM; the disease is neoplasm.